Which one is better, Hetrombopag or Avatrombopag?

Heltrombopag is suitable for adult patients with chronic primary immune thrombocytopenia (ITP) who have previously had poor response to glucocorticoids, immunoglobulins and other treatments to increase platelet count and reduce or prevent bleeding. It is also suitable for adult patients with severe aplastic anemia (SAA) who have poor response to immunosuppressive therapy (IST). Hetrombopag mainly promotes thrombopoietin (TPO) receptor-dependent 32D— The proliferation of MPL cell lines promotes the proliferation and differentiation of CD35+ cells in human umbilical cord blood, thereby improving the patient's condition and reducing the risk of bleeding diseases.

Avatrombopag is a new thrombopoietin receptor agonist that stimulates the proliferation and differentiation of megakaryocytes in the bone marrow, thereby increasing platelet production. Avatrombopag is indicated primarily for adults with thrombocytopenia associated with chronic liver disease and chronic immune thrombocytopenia.

Compared with Hatrombopag and Avatrombopag, clinical data show that Avatrombopag is more effective. Avatrombopag is a second-generation, once-daily oral thrombopoietin (TPO) receptor agonist that does not chelate polyvalent cations and can be taken with food without dietary restrictions. There are regular generic drugs on the market in Laos and Bangladesh, with specifications of 28 tablets, and each box is about 6 hundred to 9 hundred. If you want to get more high-quality information, you can contact Yaode, and Yaode will do its best to help you learn more about high-quality overseas drugs.